Acer Therapeutics Inc.
USD0.66
-0.14 (-17.95%)
CEO
Christopher Schelling
IPO Date
2004-04-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.80
Prev. Close
$0.80
Day Low
$0.66
Day High
$0.85
52W Low
$0.55
52W High
$4.56
Volume
0.57M
| -2.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -278.4% | -156.7% | 0.04 | 1.05 | -1.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -160.1% | -137.0% | 0.03 | 4.65 | -1.4 |
| 31 Dec 2018 | FY | 100.0% | -4924.8% | -47.2% | -42.0% | 0.00 | 7.66 | -8.1 |
| 31 Dec 2017 | FY | 100.0% | 5769.9% | -63.5% | -58.2% | 0.00 | 8.13 | -3.6 |
| 31 Dec 2016 | FY | 100.0% | -274.7% | -294.9% | -206.4% | 0.06 | 3.29 | -0.8 |
| 31 Dec 2015 | FY | 100.0% | -470.2% | -125.0% | -83.4% | 0.02 | 2.83 | -1.4 |
| 31 Dec 2014 | FY | 100.0% | -1183.3% | -202.3% | -127.5% | 0.00 | 3.40 | -1.5 |
| 31 Dec 2013 | FY | 100.0% | -1314.6% | -80.9% | -63.5% | 0.00 | 7.45 | -1.7 |
| -0.7 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | 62.3% | -103.9% | -1.10 | 0.20 | -0.2 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | 56.0% | -80.7% | -0.71 | 0.19 | -1.2 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | 40.9% | -32.5% | -0.68 | 0.35 | -1.1 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | 30.4% | -11.5% | -0.98 | 0.87 | -2.1 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | 90.9% | -29.2% | -1.32 | 0.85 | -1.1 |
| 31 Dec 2021 | Q4 | 100.0% | -1228.1% | 256.5% | -12.2% | -0.23 | 0.96 | -1.8 |
| 30 Sept 2021 | Q3 | 0.0% | 0.0% | -151.2% | -10.1% | 0.00 | 0.81 | -2.8 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -41.5% | -8.1% | 0.00 | 0.99 | -3.2 |